Lexicon Pharmaceuticals
LXRX
#6390
Rank
NZ$1.68 B
Marketcap
NZ$3.78
Share price
-2.40%
Change (1 day)
98.82%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): NZ-$0.12

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.12. In 2025 the company made an earnings per share (EPS) of NZ-$0.24 an increase over its 2024 EPS that were of NZ-$1.08.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.12-48.57%
2025NZ-$0.24-78.13%
2024NZ-$1.08-20%
2023NZ-$1.3531.15%
2022NZ-$1.03-0%
2021NZ-$1.0310.91%
2020NZ-$0.93-145.08%
2019NZ$2.06-206.09%
2018NZ-$1.94-5.74%
2017NZ-$2.06-10.95%
2016NZ-$2.312640%
2015NZ-$0.08448-96.34%
2014NZ-$2.31-2.53%
2013NZ-$2.37-9.09%
2012NZ-$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$30.78-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.34-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$71.86-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.32 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$13.25-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03379-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.27 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.37-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$2,765 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA